Congressionally Directed Medical Research Programs -- Ovarian Cancer Research Program -- Ovarian Cancer Academy Award -- Investigator-Initiated Research Award

Funding Agency:
Department of Defense

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature.

Deadlines:
• Required Pre-Application Deadline: April 1, 2021
• Invitation to Submit an Application:  May 2021
• Application Submission Deadline: July 8, 2021

Agency Website

Eligibility Requirements

Investigators at or above the level of Assistant Professor (or equivalent) are eligible to be named as a Principal Investigator (PI), Initiating PI, or Partnering PI on an application. There are no limitations on the number of applications for which an investigator may be named as a PI, Initiating PI, or Partnering PI. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.

Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY21 Investigator-Initiated Research Award will not exceed $600,000 for applications with a single PI or $800,000 if applying under the Partnering PI Option. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type

Grant

Eligibility

Faculty
Junior Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 1, 2021